Instil Bio, Inc. — Director's Dealing 2021

Mar 19, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2021-03-18

Reporting Person: Roberts Zachary (Chief Medical Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	120000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$0.84	2030-05-08	Common Stock (540000)		Direct
Employee Stock Option (right to buy)	$1.15	2030-06-30	Common Stock (421791)		Direct
Employee Stock Option (right to buy)	$5.95	2031-02-09	Common Stock (120000)		Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to the option vested on March 3, 2021, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

F2: Twenty-five percent (25%) of the shares subject to the option vest on July 1, 2021, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

F3: Twenty-five percent (25%) of the shares subject to the option vest on February 10, 2022, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.